Please login to the form below

Not currently logged in
Email:
Password:

Sanofi earmarks €170m for new French vaccines facility

Will expand its Val de Reuil production unit

Sanofi

French pharmaceutical company Sanofi has invested €170m to expand its existing vaccine production operations in northern France.

The new Val de Reuil facility will allow Sanofi Pasteur to increase supply of its new quadrivalent influenza vaccine VaxigripTetra.

Philippe Luscan, executive vice president, global industrial affairs, Sanofi, said: “Our investment underlines Sanofi’s intent to strengthen our industrial capacities in France as a major centre of influenza vaccines production for worldwide markets.”

Sanofi - who has made several investments to improve and expand its vaccine production capabilities - plans to complete the expansion by 2021, and will begin producing vaccines in the new facility in 2022.

David Loew, executive vice president, Sanofi, said: “Influenza continues to be a major public health problem around the world, causing serious complications, hospitalisations and deaths, mostly for certain high-risk individuals.

“As a global leader in flu vaccines, this expansion reinforces Sanofi Pasteur’s ability to tackle this underestimated health challenge.”

Article by
Gemma Jones

17th October 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...